Fri, July 20, 2012
Thu, July 19, 2012
Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012
Wed, July 11, 2012
Tue, July 10, 2012
Mon, July 9, 2012
Fri, July 6, 2012
Thu, July 5, 2012
Wed, July 4, 2012
[ Wed, Jul 04th 2012 ] - Market Wire
Warnex Announces Refinancing
Tue, July 3, 2012
Mon, July 2, 2012
Sun, July 1, 2012
Fri, June 29, 2012
Thu, June 28, 2012
Wed, June 27, 2012

Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.


//health-fitness.news-articles.net/content/2012/ .. -stockholders-of-amylin-pharmaceuticals-inc.html
Published in Health and Fitness on Monday, July 9th 2012 at 10:02 GMT by Market Wire   Print publication without navigation


Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin... -- DALLAS, July 9, 2012 /PRNewswire/ --

Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.

[ ]

DALLAS, July 9, 2012 /PRNewswire/ -- Securities lawyers at [ Goldfarb LLP ] are investigating alleged violations of shareholder protection laws by officers and directors of Amylin Pharmaceuticals, Inc. (NASDAQ: [ AMLN ]) in connection with a buyout for $31.00 per share to Bristol-Myers Squibb. Concerned AMLN investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or [ hlindley@goldfarbllp.com ] about their rights and remedies.

"Amylin's recently approved diabetes drug, Bydureon, has been noted to have huge potential in the diabetes drug market, as a wholly owned subsidiary of Bristol-Myers," said Hamilton Lindley. "Seeing this potential, AstraZeneca plans to collaborate with Bristol-Myers, following the completion of the acquisition, and making payments to Amylin as a wholly owned subsidiary of Bristol-Myers. Our potential lawsuit will seek to ensure that all important information is disclosed so that shareholder interests are protected in terms of price and information." 

Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. AMLN stockholders – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at [ hlindley@goldfarbllp.com ] or 877-583-2855 with questions or concerns.

Hamilton Lindley Goldfarb LLP 2501 N. Harwood, Ste. 1801 Dallas, TX 75201 (877) 583-2855 Toll Free Telephone (214) 583-2233 Local Phone Number (214) 583-2234 Fax Number [ www.goldfarbllp.com ]

 

 

 

SOURCE Goldfarb LLP



[ Back to top ]

RELATED LINKS
[ http://www.goldfarbllp.com/ ]


Publication Contributing Sources